Tancredi T, Salvadori S, Amodeo P, Picone D, Lazarus L H, Bryant S D, Guerrini R, Marzola G, Temussi P A
ICMIB del CNR, Napoli, Italy.
Eur J Biochem. 1994 Aug 15;224(1):241-7. doi: 10.1111/j.1432-1033.1994.tb20017.x.
The properties of di- and tri-peptides containing 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic) in second position suggest that the message domain of opioid peptides can be composed of only two residues [Temussi, P. A., Salvadori, S., Amodeo, P., Guerrini, R., Tomatis, R., Lazarus, L. H., Picone, D. & Tancredi, T. (1994) Biochem. Biophys. Res. Commun. 198, 933-939]. As a crucial test of the possibility that the Tyr-Tic segment be a message domain in longer peptide sequences, we have inserted it in the sequences of two typical opioid peptides: [Leu]enkephalin, a non-selective agonist, and dermorphin, a selective mu agonist. Here we report the synthesis and biological activity of [L-Tic2]enkephalin, [L-Tic2]dermorphin, [L-Tic2]dermorphin carboxylic acid and [D-Tic2]dermorphin: all [L-Tic2]peptides were converted from agonists to delta-selective antagonists. The NMR conformational study in a dimethylsulfoxide/water cryoprotective mixture at low temperature shows diagnostic side-chain--side-chain NOEs in the spectra of all [L-Tic2]peptides and hints that the 90 degrees arrangement of the the two aromatic rings found in the cis-Tyr-L-Tic moiety, typical of N-methyl naltrindole and other delta-selective opiate antagonists, is responsible for the antagonist activity of all these peptides.
第二个位置含有1,2,3,4 - 四氢异喹啉-3 - 羧酸(Tic)的二肽和三肽的性质表明,阿片样肽的信息域可能仅由两个残基组成[泰穆西,P. A.,萨尔瓦多里,S.,阿莫代奥,P.,圭里尼,R.,托马蒂斯,R.,拉扎勒斯,L. H.,皮科内,D. & 坦克雷迪,T.(1994年)《生物化学与生物物理研究通讯》198, 933 - 939]。作为对Tyr - Tic片段在更长肽序列中可能是信息域这一可能性的关键测试,我们将其插入到两种典型阿片样肽的序列中:[亮氨酸]脑啡肽,一种非选择性激动剂,以及皮啡肽,一种选择性μ激动剂。在此我们报告[L - Tic2]脑啡肽、[L - Tic2]皮啡肽、[L - Tic2]皮啡肽羧酸和[D - Tic2]皮啡肽的合成及生物活性:所有[L - Tic2]肽都从激动剂转变为δ选择性拮抗剂。在低温下的二甲基亚砜/水冷冻保护混合物中的核磁共振构象研究表明,所有[L - Tic2]肽的光谱中都存在具有诊断性的侧链 - 侧链核Overhauser效应(NOE),这暗示在顺式 - Tyr - L - Tic部分中发现的两个芳香环的90度排列,这是N - 甲基纳曲吲哚和其他δ选择性阿片拮抗剂的典型特征,是所有这些肽的拮抗剂活性的原因。